Founded in 1993, Biosearch Technologies, part of LGC, develops nucleic acid technologies for research, diagnostics and applied genomics. The company specialises in oligonucleotide synthesis, nucleic acid chemistry and molecular detection tools. Its technologies help researchers analyse genes, detect targets and study RNA expression. Biosearch Technologies supports workflows in genomics, molecular biology, agricultural biotechnology and translational research. Its expertise spans custom oligonucleotides, assay development and nucleic acid manufacturing. These capabilities support applications including qPCR, genotyping, gene expression analysis and molecular diagnostics.
The company's portfolio includes custom primers, probes and oligonucleotides, together with fluorescent dyes and quencher chemistries. Key product families include Black Hole Quencher™ (BHQ™), BHQplus™, BHQnova™, CAL Fluor™, Quasar™ and Stellaris™ RNA FISH probes. Biosearch Technologies also provides ValuMix™ and ValuPanel™ assay products, as well as MerMade™ oligonucleotide synthesizers. These technologies support SNP genotyping, multiplex qPCR, RNA visualisation and assay development. The portfolio also includes reagents for oligonucleotide modification and large-scale synthesis workflows.
Europa Biosite subsidiaries distribute for LGC Biosearch Technologies in Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, Switzerland and the United Kingdom.
